Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference40 articles.
1. Vectibix® (panitumumab). Full prescribing information. Amgen Inc., Thousand Oaks, CA, 2017.
2. Vectibix (panitumumab). Summary of product characteristics. Amgen Europe B.V., Breda, Netherlands, 2018.
3. Battaglin F, Puccini A, Ahcene Djaballah S, et al. The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer. Cancer Manag Res. 2019;11:5911–24.
4. Hendrikx J, Haanen J, Voest EE, et al. Fixed dosing of monoclonal antibodies in oncology. Oncologist. 2017;22(10):1212–21.
5. Hendrikx JJMA, Beijnen JH, Huitema ADR. Is bodyweight-based dosing truly better than flat dosing for panitumumab? [Letter]. Clin Pharmacol Adv Appl. 2020;12:177–8.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献